Position in ABBV
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$652,250
+$81,122 QoQ
Shares Held
2,592
-1.3% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.29%
of 13F equity value
Holder Rank
#2,934
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Argent Advisors, Inc. holds $22,940,677 across 9 Drug Manufacturers - General names. ABBV ranks #8 (2.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
4,391 | $5,266,697 | |
| 2 | JNJ |
Johnson & Johnson
|
20,074 | $5,098,193 | |
| 3 | MRK |
Merck & Co., Inc.
|
24,547 | $3,154,289 | |
| 4 | GSK |
GSK plc
|
51,943 | $2,722,852 | |
| 5 | PFE |
Pfizer Inc
|
109,643 | $2,640,203 | |
| 6 | AMGN |
Amgen Inc
|
4,586 | $1,660,682 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
11,701 | $1,478,304 | |
| 8 | ABBV |
AbbVie Inc.
This page
|
2,592 | $652,250 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $652,250 | 2,592 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $571,128 | 2,626 | Shares | Sole | 2026-04-24 | |
| 2025-12-31 | $638,172 | 2,793 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $649,469 | 2,805 | Shares | Sole | 2025-11-03 | |
| 2025-06-30 | $436,578 | 2,352 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $478,124 | 2,282 | Shares | Sole | 2025-04-25 | |
| 2024-12-31 | $391,650 | 2,204 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $460,325 | 2,331 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $425,369 | 2,480 | Shares | Sole | 2024-07-29 | |
| 2024-03-31 | $514,250 | 2,824 | Shares | Sole | 2024-05-01 | |
| 2023-12-31 | $573,389 | 3,700 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $572,837 | 3,843 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $543,231 | 4,032 | Shares | Sole | 2023-08-04 | |
| 2023-03-31 | $698,518 | 4,383 | Shares | Sole | 2023-04-24 | |
| 2022-12-31 | $686,519 | 4,248 | Shares | Sole | 2023-02-02 | |
| 2022-09-30 | $561,400 | 4,183 | Shares | Sole | 2022-11-08 | |
| 2022-06-30 | $611,721 | 3,994 | Shares | Sole | 2022-08-08 | |
| 2022-03-31 | $720,903 | 4,447 | Shares | Sole | 2022-04-26 | |
| 2021-12-31 | $551,484 | 4,073 | Shares | Sole | 2022-02-02 | |
| 2021-09-30 | $221,780 | 2,056 | Shares | Sole | 2021-11-05 | |
| 2021-06-30 | $228,771 | 2,031 | Shares | Sole | 2021-08-02 | |
| 2021-03-31 | $216,007 | 1,996 | Shares | Sole | 2021-04-27 | |
| 2020-12-31 | $491,497 | 4,587 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $371,118 | 4,237 | Shares | Sole | 2020-10-29 | |
| 2020-06-30 | $415,988 | 4,237 | Shares | Sole | 2020-08-11 | |
| 2020-03-31 | $214,170 | 2,811 | Shares | Sole | 2020-04-23 | |
| No filing history on record for this holder in this stock. | ||||||